AEZSAeterna Zentaris Inc.

Nasdaq zentaris.com


$ 8.19 $ 0.04 (0.5 %)    

Tuesday, 07-May-2024 13:37:29 EDT
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 8.03
$ 8.17
$ 0.00 x 0
$ 0.00 x 0
$ 8.17 - $ 8.19
$ 5.44 - $ 13.20
10,440
na
9.75M
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aeterna-zentaris-q4-2023-gaap-eps-116-misses-097-estimate-sales-100000k-down-from-2485m-yoy

AEterna Zentaris (NASDAQ:AEZS) reported quarterly losses of $(1.16) per share which missed the analyst consensus estimate of $(...

 hc-wainwright--co-maintains-buy-on-aeterna-zentaris-lowers-price-target-to-15

HC Wainwright & Co. analyst Raghuram Selvaraju maintains AEterna Zentaris (NASDAQ:AEZS) with a Buy and lowers the price ...

 aeterna-zentaris-q3-eps-085-misses-061-estimate

AEterna Zentaris (NASDAQ:AEZS) reported quarterly losses of $(0.85) per share which missed the analyst consensus estimate of $(...

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 369 companies hit new 52-week lows.

 hc-wainwright--co-reiterates-buy-on-aeterna-zentaris-maintains-28-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates AEterna Zentaris (NASDAQ:AEZS) with a Buy and maintains $28 pr...

 aeterna-zentaris-q2-eps-052-beats-087-estimate-sales-225m-beat-114m-estimate

AEterna Zentaris (NASDAQ:AEZS) reported quarterly losses of $(0.52) per share which beat the analyst consensus estimate of $(0....

 hc-wainwright--co-reiterates-buy-on-aeterna-zentaris-maintains-28-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates AEterna Zentaris (NASDAQ:AEZS) with a Buy and maintains $28 pr...

 aeterna-zentaris-says-encouraged-by-progress-across-all-of-its-active-development-programs

The company reports strong financial position with cash projected to fund operations and advancement of priority pipeline progr...

 hc-wainwright--co-reiterates-buy-on-aeterna-zentaris-maintains-28-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates AEterna Zentaris (NASDAQ:AEZS) with a Buy and maintains $28 pr...

 aeterna-zentaris-q1-eps-088-beats-107-estimate-sales-210m-beat-90000k-estimate

AEterna Zentaris (NASDAQ:AEZS) reported quarterly losses of $(0.88) per share which beat the analyst consensus estimate of $(1....

 hc-wainwright--co-reiterates-buy-on-aeterna-zentaris-maintains-28-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates AEterna Zentaris (NASDAQ:AEZS) with a Buy and maintains $28 pr...

 aeterna-zentaris-says-us-sales-of-macrilen-for-adult-use-will-be-temporarily-discontinued-as-of-may-23-until-relaunch-with-an-alternate-commercialization-partner

U.S. sales of Macrilen® for adult use to be temporarily discontinued as of May 23, 2023, while DETECT trial continues in orde...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION